Analysis of the crystal structure reveals intricate molecular details in a halogenated compound.
C 17 H 11 ClINO 3 , monoclinic, C 2/ c (no. 15), a = 50.730(3) Å, b = 5.1591(2) Å, c = 30.2842(12) Å, β = 125.053(4)°, V = 6488.4(6) Å 3 , Z = 16, R gt ( F ) = 0.0434, w R ref ( F 2 ) = 0.1248, T = 293(2) K.
No takes yet. Share an insight, caveat, or question.
Yu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: